这页已由机器翻译。其他页面可能仍然显示为英文。 View in English

罗和吉对有关"内皮细胞HDAC1-ZEB2-NuRD复合体通过调节蛋白S-硫化驱动大动脉动脉瘤和解剖"的信件的回应

  • 0Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, Nanjing, China (S.L., Y.J.).

|

概括

No abstract available on PubMed

相关概念视频